Vanguard Group Inc Beam Therapeutics Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 7,844,606 shares of BEAM stock, worth $211 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,844,606

Previous 7,900,379 0.71%

Holding current value

$211 Million

Previous $185 Million 3.83%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$22.57 - $33.14 $1.26 Million - $1.85 Million	-55,773 Reduced 0.71%	7,844,606 $192 Million
Q2 2024 Aug 13, 2024	BUY	$21.22 - $32.66 $6.82 Million - $10.5 Million	321,611 Added 4.24%	7,900,379 $185 Million
Q1 2024 May 10, 2024	BUY	$23.46 - $45.07 $9.71 Million - $18.7 Million	413,892 Added 5.78%	7,578,768 $250 Million
Q4 2023 Feb 14, 2024	BUY	$17.69 - $30.76 $6.19 Million - $10.8 Million	349,906 Added 5.13%	7,164,876 $195 Million
Q3 2023 Nov 14, 2023	SELL	$23.01 - $32.46 $4.49 Million - $6.33 Million	-195,009 Reduced 2.78%	6,814,970 $164 Million
Q2 2023 Aug 14, 2023	BUY	$29.32 - $35.99 $18.3 Million - $22.5 Million	624,488 Added 9.78%	7,009,979 $224 Million
Q1 2023 May 15, 2023	BUY	$30.15 - $48.79 $3.37 Million - $5.46 Million	111,861 Added 1.78%	6,385,491 $196 Million
Q4 2022 Feb 10, 2023	BUY	$36.73 - $51.6 $3.64 Million - $5.12 Million	99,159 Added 1.61%	6,273,630 $245 Million
Q3 2022 Nov 14, 2022	BUY	$39.79 - $70.31 $36.9 Million - $65.2 Million	927,970 Added 17.69%	6,174,471 $294 Million
Q2 2022 Aug 12, 2022	BUY	$29.86 - $62.36 $16 Million - $33.3 Million	534,491 Added 11.34%	5,246,501 $203 Million
Q1 2022 May 13, 2022	BUY	$53.73 - $82.16 $792,248 - $1.21 Million	14,745 Added 0.31%	4,712,010 $270 Million
Q4 2021 Feb 14, 2022	BUY	$68.02 - $99.06 $12.3 Million - $17.9 Million	180,565 Added 4.0%	4,697,265 $374 Million
Q3 2021 Nov 12, 2021	BUY	$84.37 - $133.6 $91.2 Million - $144 Million	1,081,128 Added 31.47%	4,516,700 $393 Million
Q2 2021 Aug 13, 2021	BUY	$64.12 - $128.71 $220 Million - $442 Million	3,435,572 New	3,435,572 $442 Million

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.89B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Beam Therapeutics Inc. Transaction History